1
/
of
0
Redacted FDA Decision Memorandum - Eli Lilly's Tirzepatide Drug Shortage (Dec 19, 2024)
Redacted FDA Decision Memorandum - Eli Lilly's Tirzepatide Drug Shortage (Dec 19, 2024)
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Request Contents: Redacted FDA Decision Memorandum (December 19, 2024) regarding the resolution of Eli Lilly's tirzepatide drug shortage.
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details